Gastrointestinal stromal tumor | Tumor

Advanced-Stage Rare Type of Gastrointestinal Cancer More Common in Men, Associated with ‘Excellent’ 5-Year Survival Rates

January 19th 2021, 4:00pm

The data in the study presented at the ASCO Gastrointestinal Cancers Symposium demonstrated that while rare, stage 4 gastrointestinal stromal tumors often spread to the liver.

Novel Artificial Intelligence Tool May Help Patients with Cancer Find, Understand Clinical Trials

January 18th 2021, 10:00pm

A group of patients with gastrointestinal cancers reported that a novel artificial intelligence-based search tool made it easier for them to find and understand cancer clinical trials. The tool, according to study authors, would not only help with trial accrual, but could also help improve trial diversity.

FDA Approves Qinlock for Patients with Pretreated, Advanced GIST

May 16th 2020, 1:26am

The targeted drug Qinlock, which interferes with the activity of proteins that drive gastrointestinal stromal tumor, has been approved by the Food and Drug Administration for patients with advanced disease that has progressed despite treatment with other kinase inhibitors.

What You Need to Know About the FDA's Approval of Avyakit for GIST Subgroup

January 13th 2020, 9:17pm

Patients with gastrointestinal stromal tumors have a new targeted therapy that looks to tackle secondary mutations after it showed a strong response rate in the clinic.

FDA Approves Ayvakit for the Treatment of Certain Patients with Gastrointestinal Stromal Tumor

January 10th 2020, 3:29am

The Food and Drug Administration approved Ayvakit for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumor who exhibited a platelet-derived growth factor receptor alpha exon 18 mutation.

Hitting a Target in Gastrointestinal Stromal Tumors

August 2nd 2017, 8:23pm

How zeroing in on the mutation in gastrointestinal stromal tumors is adding years to patients’ lives

Collaboration Lays the Groundwork for Breakthroughs in GIST

January 29th 2017, 10:33pm

The Life Raft Group, a patient advocacy organization, is teaming up with research organizations to hopefully find the next wave of treatment for patients with gastrointestinal stromal tumors.

Gastrointestinal Stromal Tumors Already Proving to Be Treatable With Targeted Therapies

March 23rd 2016, 11:39pm

Identified only a decade-and-a-half ago, GIST is already treatable with several targeted therapies, and scientists are researching more.

GIST: Symptoms, Treatments, and Side Effect Management

October 22nd 2015, 1:15am

Part VI: How GIST and I Became Acquainted

August 25th 2015, 5:59pm

Moving back into the light.